𝔖 Bobbio Scriptorium

✦ LIBER ✦

PCN18 ECONOMIC EVALUATION OF SUNITINIB VS. IMATINIB IN SECOND LINE FOR GASTROINTESTINAL TUMOR (GIST) IN BRAZIL

✍ Scribed by Teich, N; Hashizume, C; Follador, W

Book ID: 122142409
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 64 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1016/S1098-3015(10)75345-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patterns of Care, Prognosis, and Surviva

Patterns of Care, Prognosis, and Survival in Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Refractory to First-Line Imatinib and Second-Line Sunitinib

✍ Antoine Italiano; Angela Cioffi; Paola Coco; Robert G. Maki; Patrick Schöffski; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 384 KB

4526 POSTER Safety profile of single-age

4526 POSTER Safety profile of single-agent sunitinib malate from the French Temporary Authorization for Use program (Cohort ATU) in metastatic renal cell carcinoma (MRCC) after failure of treatment with cytokines and gastrointestinal stromal tumor (GIST) patients after failure of imatinib mesylate treatment

✍ Oudard, S.; Negrier, S.; Ferrero, J.M.; Gravis, G.; Blay, J.Y.; Le Cesne, A.; Kr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB